Ferric Carboxymaltose in the Treatment of Anemia in Patients with Locally Advanced Colon Cancer
Introduction. The incidence of anemia in colorectal cancer patients reaches 30–67% depending on the stage and location of the tumor; the presence of anemia adversely affects the short-term and long-term results of radical treatment. One possible way of anemia correction is to parenterally administer...
Saved in:
| Main Authors: | D. O. Kornev, A. N. Moskalenko, E. S. Kuzmina, V. K. Lyadov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bashkir State Medical University
2025-04-01
|
| Series: | Креативная хирургия и онкология |
| Subjects: | |
| Online Access: | https://www.surgonco.ru/jour/article/view/1047 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of ferric carboxymaltose in the iron deficiency anemia patients undergoing cardiac surgery: A randomized clinical trial
by: Fateme Ramezani, et al.
Published: (2024-05-01) -
A retrospective study of the results of intravenous use of iron carboxymaltosate in a short period of time before cardiac surgery
by: А. V. Stepin
Published: (2025-01-01) -
Transient Hypophosphatemia as Possible Adverse Outcome after Iron Deficiency Anemia Treatment with Ferric Carboxymaltose – Single Center Experience
by: Nikolina Brkić, et al.
Published: (2024-01-01) -
Evaluation of Anemia in the Pediatric Population in an Academic Medical Center: An Institutional Study from a Low- and Middle-income Country
by: Bhawna Kumari, et al.
Published: (2025-04-01) -
Comparative Impact of Intravenous Iron Sucrose and Ferric Carboxymaltose on Hypophosphatemia and Anemia Parameters in Iron Deficiency Anemia: A Retrospective Study
by: Aslan S, et al.
Published: (2025-06-01)